6-(Trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-2-carboxylic acid, 97.0%, 1g

2,6-Bis(benzyloxy)-3-(4-bromo-2,6-difluorophenyl)pyridine, 98%, 5g

1-Bromo-3,7-dimethyloctane, 95.0%, 1g

1-[4-Hydroxy-2-(trifluoromethyl)phenyl]ethanone, 97.0%, 1g

5-(3-(4-(4-Chlorophenyl)piperidin-1-yl)propyl)pyrrolo[1,2-a]quinoxalin-4(5H)-one, 97.0%, 5mg

1-tert-Butyl L-Glutamate>98.0%(T)25g

GC capillary column ROTI®Cap-5 MS, 50 m, 0.20 mm, 0.35 µm, 1 Piece(s)

(5-Chloro-3-pyridinyl)methanol, 95.0%, 1g

N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-3H-purin-2-yl)isobutyramide, 97%, 100mg

2-Amino-5-nitropyridine, 99.00%, 25g

2-(ETHYLAMINO)-PHENOL, 250mg

2,3-Dimethylsuccinic acid, 95.0%, 1g

2,3-Butanediol (mixture of stereoisomers), 97.0%, 500g